A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 Omicron variant, according to a new study.
Qatar Omicron-wave study shows slow decline of natural immunity, rapid decline of vaccine immunity
